Let's catch up on the latest news from the stock market. From significant investments to major deals, order wins, appointments and acquisitions, here’s a quick look at which stocks will be in focus in today's trade:
Stocks to Watch
The Board has re-appointed Rajivnayan Rahulkumar Bajaj as the Managing Director & Chief Executive Officer of the company for five consecutive years, effective April 1. Additionally, Abhinav Bindra has been appointed as a Non-executive Independent Director of the company for five years, effective May 20. The Board has also approved an additional fund infusion of up to Rs 1,500 crore in the company's subsidiary, Bajaj Auto Credit, in one or more tranches.
The pharmaceutical company has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Apalutamide tablets in a 60 mg strength. Apalutamide is an androgen receptor inhibitor used for the treatment of patients with metastatic castration-sensitive prostate cancer. Apalutamide tablets had annual sales of $1,099.8 million in the United States, according to IQVIA MAT January 2025.
The company has received a Letter of Acceptance from the National Highways Authority of India for a project worth Rs 4,262.78 crore. The project involves the construction of the Agra-Gwalior Greenfield road in Uttar Pradesh, Rajasthan, and Madhya Pradesh on a DBFOT pattern under the BOT (Toll) Mode, as part of the NH(O) scheme.
The Board will meet on March 21 to consider fund raising through the issuance of non-convertible debentures (Tier II bonds) on a preferential basis.
The company's subsidiary, Granules Europe at Bath, United Kingdom, has been voluntarily dissolved, effective March 18, due to a strategic change in the business model.
Akshay Jatia has been elevated to Chief Executive Officer (CEO) of the company, replacing Amit Jatia, who will cease to be a key managerial personnel, effective March 18. Amit Jatia and Akshay Jatia will continue as directors of the company, with no change in the composition of the Board of Directors. Akshay Jatia is currently the Executive Director (Whole Time Director) of the company.
As part of right-sizing the group entities and eliminating non-operating entities, the company's step-down subsidiary, Generic Partners UK, has been voluntarily dissolved, effective March 18. Generic Partners UK was a non-operating company, and its contribution to the consolidated turnover of the company for FY24 was nil.
Andrew Jones has resigned as CEO, Europe of the company. He will be relieved of his duties, effective May 31.
Life Insurance Corporation of India
LIC has issued a clarification note on media reports that the company is looking to enter the health insurance business. In this regard, LIC stated that it is still in advanced talks with a standalone health insurance company to acquire a substantial stake to broaden the Corporation's footprint in the health insurance market. However, no binding agreement has been entered into. The execution and consummation of the deal are subject to regulatory approvals, and there can be no guarantee or assurance of the execution/consummation of the potential deal.
The company, along with Nasdaq-listed global biotech company Alvotech, announced that the US Food and Drug Administration (FDA) has accepted a 351(k) Biologic License Application (BLA) submission for AVT03, developed by Alvotech. AVT03 is a proposed biosimilar of Prolia (denosumab) and Xgeva (denosumab).
The company has received approvals from the BSE and National Stock Exchange India for the reclassification of Lavanya Sankaran from the promoter & promoter group to the public shareholder category.
The Board meeting is scheduled for March 21 to consider fund raising via a debt issue.
In a significant advancement in sustainable aviation, Bharat Petroleum Corporation (BPCL) has entered into a quadripartite Memorandum of Understanding (MoU) with BluJ Aerospace, the Agency for New and Renewable Energy Research and Technology (ANERT), the Government of Kerala, and Cochin International Airport (CIAL) to develop the first hydrogen-fueled Vertical Take-off and Landing (VTOL) aircraft ecosystem globally.
The company has completed the investment and acquired a 45.33% stake in Bhairav Robotics. Bhairav has now become an associate company of Zen Technologies.
The company's subsidiary, Flex Middle East, FZE, Dubai, has incorporated a step-down subsidiary, Flex Films AZB AFEZCO, in Azerbaijan. This new subsidiary will set up a facility for manufacturing biaxially oriented polypropylene (BOPP) packaging film in Azerbaijan and sell it in the domestic market as well as in other adjoining CIS and European countries.
Bulk Deals
Brookfield India Real Estate Trust REIT
Sponsors BSREP India Office Holdings Pte Ltd and BSREP India Office Holdings IV Pte Ltd sold 1.57 crore units in the REIT at an average price of Rs 283 per unit, and 1.54 crore units at an average price of Rs 283.04 per unit, respectively. 360 ONE Portfolio Managers and 360 ONE Prime acquired 1.18 crore units in the REIT at an average price of Rs 283 per unit.
Sun-N-Sand Hotels bought a 0.58% stake in the company at an average price of Rs 17.09 per share.
SME Listing on March 19
Super Iron Foundry
Stocks Trade Ex-Dividend
Power Finance Corporation
AGI Infra
Stocks in F&O ban
BSE
IndusInd Bank
Hindustan Copper
Manappuram Finance
SAIL
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
